Abeliovich Asa 4
4 · Prevail Therapeutics Inc. · Filed Mar 11, 2020
Insider Transaction Report
Form 4
Abeliovich Asa
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-02-19+250,000→ 250,000 totalExercise: $16.91Exp: 2030-02-19→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares underlying the option vest and become exercisable on February 19, 2021 and an additional 1/48th of the total number of shares underlying the option shall vest and become exercisable on the same date of each of the thirty-six (36) consecutive months thereafter subject, in all cases, to the Reporting Person providing continuous service with the Issuer on each such date.